Trials / Completed
CompletedNCT01279265
Effect of Lactobacillus Rhamnosus GG (LGG) on Infant Colic
Effect of Lactobacillus Rhamnosus GG (LGG) on Infant Crying, Intestinal Microbiota, and Intestinal Inflammation in Infants With Colic
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- The University of Texas Health Science Center, Houston · Academic / Other
- Sex
- All
- Age
- 3 Weeks – 3 Months
- Healthy volunteers
- Accepted
Summary
This study will compare 2 currently marketed formulas in healthy full term babies: Nutramigen A+ (a hypoallergenic formula) and Nutramigen-Enflora (hypoallergenic formula with Lactobacillus GG (LGG)) during 3 months of formula feeding. The investigators' aims are to compare 3 outcomes in these babies: (1) normal baby crying time; (2) the composition of intestinal microbiota (bacteria in the stool); and (3) a lab test which measures the number of white blood cells in the large intestine (fecal calprotectin). The investigators predict that LGG supplementation (Nutramigen-Enflora) will facilitate its establishment as an important component of the neonatal intestinal microbial community and reduce fecal calprotectin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Nutramigen with Enflora | Hypoallergenic formula with probiotic - Lactobacillus GG |
| DIETARY_SUPPLEMENT | Nutramigen A+ | Hypoallergenic formula without lactobacillus |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2011-01-19
- Last updated
- 2015-11-11
- Results posted
- 2015-11-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01279265. Inclusion in this directory is not an endorsement.